• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Mass layoffs start at HHS: ‘FDA as we’ve known it is finished’

Mass layoffs start at HHS: ‘FDA as we’ve known it is finished’

April 1, 2025 By Jim Hammerand

A photo of U.S. Department of Health & Human Services Secretary Robert F. Kennedy Jr. (center) with new FDA Commissioner Dr. Marty Makary (right) and NIH Director Dr. Jay Bhattacharya.
U.S. Department of Health & Human Services Secretary Robert F. Kennedy Jr. (center) with new FDA Commissioner Dr. Marty Makary (right) and NIH Director Dr. Jay Bhattacharya. [Photo courtesy of HHS]
The Trump Administration has started mass layoffs at the FDA, CDC, NIH and other agencies within the Department of Health and Human Services, following up on a plan announced last week for Elon Musk’s DOGE team to shrink the workforce by 20,000 people through voluntary separations and new terminations.

UPDATE: FDA’s chief medical officer is out after HHS layoffs; Reports surface other leaders and teams who were cut

“The FDA as we’ve known it is finished, with most of the leaders with institutional knowledge and a deep understanding of product development and safety no longer employed,” former FDA Commissioner Dr. Robert Califf said on LinkedIn, calling it “a dark day for public health.”

“I believe that history will see this a huge mistake,” he continued, noting he’s been and noting he’s been “overwhelmed with messages about the firings.”

“I will be glad if I’m proven wrong, but even then there is no good reason to treat people this way,” Califf said. “It will be interesting to hear from the new leadership how they plan to put Humpty Dumpty’ back together again.”

Previously: Califf weighs in on Trump’s election as he plans his own exit: ‘Stand by the people’

HHS previously said FDA inspectors and drug, medical device and food reviewers will not be affected by the cuts, but Barron’s reports the terminations include Dr. Peter Stein, the longtime head of FDA’s Office of New Drugs.

“The loss of staff with huge experience, dedication, and expertise — in essential roles — will undermine critical functions at FDA,” Stein told the publication. “It’s hard to imagine more foolish, poorly considered, and thoughtless actions—actions that will hurt Americans.”

The cuts also included at least four directors of the NIH’s 27 institutes and centers and “nearly entire communications staffs,” according to the Associated Press, which also reported “extensive layoffs in programs that track asthma, air pollution, smoking, gun violence, reproductive health, climate change and other health threats” at the CDC and “less drastic” cuts at the Centers for Medicare and Medicaid Services.

Former FDA Office of External Affairs Associate Commissioner Erica Jefferson said “the entire FDA media team” has been eliminated, along with “CBER, CDER, CDRH, CVM and Office of Foods communications teams who worked with the Office of the Commissioner communicators to ensure timely and accurate public health information was disseminated to the public” and most of the Center for Tobacco Products communications team.

“Imagine waking up to learn that the FDA as you know it no longer exists,” she said on LinkedIn. “America, buckle up because it’s going to be a very bumpy and likely deadly carnival ride.”

Related: Former CDRH Director Jeff Shuren on what FDA cuts might mean for device developers

Major medical device manufacturers have mostly stayed publicly silent on the layoffs, while industry group AdvaMed last week said that HHS and its subagencies should be “more efficient and accountable” and that “any reduction in force should be accompanied by policy and regulatory improvements that encourage innovation in medtech.”

But some medtech leaders are speaking out.

“Reasonable and appropriate regulation of healthcare technology is vital to support not just patient safety but also public trust in innovation,” Adona Medical President and CEO Brian Fahey said on LinkedIn. “The ongoing gutting of the FDA is likely to cause American deaths.”

Medtech manufacturers are also bracing for a new round of import taxes as Trump promises to implement sweeping tariffs this week, which could increase costs for medtech materials, components and finished devices.

The reduction in federal spending combined with new taxes on buyers of goods imported to the U.S. are making a higher inflation and a recession more likely, Goldman Sachs and other analysts are warning.

Manufacturers outside of medtech are also warning of the disruption that Trump’s policies are causing, saying they’re losing business and having a harder time planning for the future.

Former Medtronic CEO Bill George recently weighed in on what he called the Trump Administration’s “game plan,” quoting from a 2021 interview of JD Vance in which he said, “We really need to be really ruthless when it comes to the exercise of power.”

“The challenge confronting American conservatives is that we have lost every major powerful institution in the country except for maybe churches and religious institutions, which of course are weaker now than they’ve ever been,” said Vance, who is now the nation’s vice president. “We’ve lost big business. We’ve lost finance. We’ve lost the culture. We’ve lost the academy. And if we’re going to actually really effect real change in the country, it will require us completely replacing the existing ruling class with another ruling class.”

Remote medtech jobs: These medical device employers have remote job openings

Filed Under: Food & Drug Administration (FDA), News Well, Regulatory/Compliance Tagged With: CDC, Centers for Medicare and Medicaid Services, FDA, imports, Layoffs, NIH, tariffs, taxes, U.S. Department of Health and Human Services

More recent news

  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform
  • MiniMed completes split from Medtronic
  • GE HealthCare’s on-site cyclotron for PET agent production claims CE Mark

About Jim Hammerand

Jim Hammerand is the managing editor of Arrowfly's MassDevice and Medical Design & Outsourcing, where he leads coverage of medtech innovation, design, engineering and manufacturing. He also contributes to our Devicetalks podcasts and live events. Hammerand has more than two decades of journalism experience spanning newspapers, magazines, websites, live events, radio and TV news. For nearly a decade, Hammerand reported and edited business news for American City Business Journals as a reporter and digital editor at the Minneapolis/St. Paul Business Journal and then as managing editor of the Puget Sound Business Journal in Seattle. He holds degrees in journalism and management from the University of Minnesota and has won journalism awards from the Society of Professional Journalists, American Society of Business Publication Editors, and Trade, Association, Business Publications International. Connect with him on LinkedIn or by email at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy